PHARMACEUTICAL REAL GROWTH OF 10.1% IN 1996 WAS DRIVEN BY MANAGED CARE, IMS AMERICA SAYS: MANAGED CARE PATIENTS ARE GETTING MORE UNITS, SHELTER FROM COST
Executive Summary
The dominance of managed care in the payment for pharmaceuticals is largely responsible for an "unprecedented" 10.1% real growth rate in the pharmaceutical industry in 1996, IMS VP-Global Client Services Richard Fehring said April 14 at a New York City press briefing.